Article
Conditional cell-wall mutants of Saccharomyces cerevisiae as delivery vehicles for therapeutic agents in vivo to the GI tract.
Journal of biotechnology - 17 May 2010
Omara Walid A M, Rash Bharat M, Hayes Andrew, Wickham Martin S J, Oliver Stephen G, Stateva Lubomira I
Abstract excerpt
Strains of Saccharomyces cerevisiae capable of lysis upon conditional down-regulation of cell-wall biogenesis genes (SRB1 and PKC1) have been reported. Here, we show that they lyse and release recombinant protein not only under laboratory conditions, but (more importantly) under conditions found in the human stomach and duodenum. These findings provide proof that, in principle, such conditional lysis strains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
